{"id":62234,"date":"2025-11-20T01:05:39","date_gmt":"2025-11-20T00:05:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/"},"modified":"2025-11-20T01:05:39","modified_gmt":"2025-11-20T00:05:39","slug":"susannah-cantrell-joins-ossium-health-as-chief-commercial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/","title":{"rendered":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its leadership team as Chief Commercial Officer (CCO).<\/p>\n

<\/a>
<\/a><\/p>\n

\nIn her new role, Dr. Cantrell will be responsible for leading Ossium\u2019s commercial strategy, go-to-market planning, and partnerships as the company scales its unique platform to meet the needs of the bone marrow transplant field. She will play a critical role in driving the company\u2019s platform from development into full-scale commercial availability.<\/p>\n

\n\u201cSusannah brings a rare combination of commercial leadership, scientific rigor, and operational excellence \u2014 exactly what Ossium needs as we advance our platform,\u201d said Kevin Caldwell, Co-Founder & CEO of Ossium Health. \u201cHer track record of building high-performing commercial teams, especially in complex, regulated environments, will be invaluable as we expand adoption of our organ donor bone marrow.\u201d<\/p>\n

\nDr. Cantrell brings more than two decades of experience in biotechnology and pharmaceuticals. Most recently, she served as Chief Business Officer at Brii Biosciences where she oversaw business development, alliance management, and commercial activities.<\/p>\n

\nPrior to Brii Biosciences, Dr. Cantrell served as Chief Business Officer and Chief Operating Officer at Second Genome, where she oversaw the company\u2019s operations, business development, finance, and facilities. Dr. Cantrell also served as Executive Vice President & Chief Commercial Officer at Tricida, where she built a U.S.-focused commercial organization from the ground up. She held senior leadership roles at Gilead Sciences, including Vice President, Global Commercial Strategy & Marketing \u2013 Oncology, where she played a key part in growing Gilead\u2019s oncology and inflammation business lines. Earlier in her career, Dr. Cantrell held various global sales and marketing roles at Genentech\/Roche and GlaxoSmithKline.<\/p>\n

\nDr. Cantrell holds a B.A. in Biology from Westminster College and a Ph.D. in Biochemistry from the University of Missouri-Columbia.<\/p>\n

\n\u201cI am thrilled to join Ossium Health at such an exciting time in its journey,\u201d said Dr. Cantrell. \u201cTheir platform has the potential to fundamentally change how we think about cell therapy, and I look forward to working with the team to bring those innovations to patients.\u201d<\/p>\n

\nHer appointment marks a significant step in strengthening Ossium\u2019s leadership as the company prepares for its next phase of growth, advancing commercial readiness and supporting the upcoming launch of its bone marrow at transplant centers nationwide.<\/p>\n

\nAbout Ossium Health<\/b><\/p>\n

\nOssium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Founded in 2016, the company is led by Kevin Caldwell, Chief Executive Officer, President and Co-Founder, and Erik Woods, Chief Science Officer, Executive Vice President and Co-Founder. Ossium Health\u2019s manufacturing facility is registered with the FDA and its laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA). For more information, please visit https:\/\/ossiumhealth.com<\/a>.<\/p>\n

\nFollow the company on LinkedIn at https:\/\/www.linkedin.com\/company\/ossiumhealth\/<\/a> and X at https:\/\/x.com\/ossiumhealth<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nJane Griffin
\n
Ossium Health, Inc.
\n
415-513-5535
\n
press@ossiumhealth.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its leadership team as Chief Commercial Officer (CCO). In her new role, Dr. Cantrell will be responsible for leading Ossium\u2019s commercial strategy, go-to-market planning, and partnerships … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62234","6":"format-standard","7":"category-industry"},"yoast_head":"\nSusannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its leadership team as Chief Commercial Officer (CCO). In her new role, Dr. Cantrell will be responsible for leading Ossium\u2019s commercial strategy, go-to-market planning, and partnerships ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T00:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer\",\"datePublished\":\"2025-11-20T00:05:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119271238\\\/en\\\/2127491\\\/22\\\/Ossium_Health_Logo_No_Slogan.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/\",\"name\":\"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119271238\\\/en\\\/2127491\\\/22\\\/Ossium_Health_Logo_No_Slogan.jpg\",\"datePublished\":\"2025-11-20T00:05:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119271238\\\/en\\\/2127491\\\/22\\\/Ossium_Health_Logo_No_Slogan.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251119271238\\\/en\\\/2127491\\\/22\\\/Ossium_Health_Logo_No_Slogan.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its leadership team as Chief Commercial Officer (CCO). In her new role, Dr. Cantrell will be responsible for leading Ossium\u2019s commercial strategy, go-to-market planning, and partnerships ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-20T00:05:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer","datePublished":"2025-11-20T00:05:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/"},"wordCount":528,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/","url":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/","name":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg","datePublished":"2025-11-20T00:05:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251119271238\/en\/2127491\/22\/Ossium_Health_Logo_No_Slogan.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Susannah Cantrell Joins Ossium Health as Chief Commercial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62234"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62234\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}